Skip to main content
Equibles
ATRC logo

ATRC · AtriCure, Inc.

Track ATRC — free

Use ATRC with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about ATRC

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$48.98 +1.49 (+3.14%) At close · Aug 21
Market Cap
$2.42B
Shares
50.87M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$48.98 Open$47.50 Day$46.99–49.20 52W close$25.86–48.98 Avg vol 30d846K Short int3.9M · 7.6% float · 3.7d Short vol65% Last earningsJul 23, 2026 DataJan 2020–Aug 2026 Filing10-Q · Jul 27

Up next

Next earnings call
Oct 17, 2026 Est · unconfirmed · in 8 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Jul 27, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Buy
      SellHoldBuy
      Technical Buy Momentum Very Strong Sentiment Bullish Fundamentals Excellent Quant / Vol High
      Market backdrop VIX 15.1 · calm Equity put/call 0.58
      Technical
      price trend
      Buy
      50 / 200-day cross No cross
      Price vs 200-day avg +46%
      above
      Price vs 50-day avg +37%
      above
      RSI (14) 84
      overbought
      MACD trend Positive
      52-week position 100%
      near high
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Very Strong
      1-month return +40%
      trailing
      6-month return +58%
      trailing
      YTD return +24%
      this year
      Relative strength +47%
      vs S&P · 6-mo
      Sentiment
      smart money
      Bullish
      Trend (MA cross) No cross
      50d $36 › 200d $34 — 50d above 200d
      Institutional flow Accumulating
      +13% holders QoQ · +55 funds added
      Insider flow Distributing
      Net -$1.7M over 90 days · 100% sells
      Short interest Falling
      7.60% of float · ▼ -20.6% MoM · 3.7 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      252 holders — near 3-yr high, broad support
      Squeeze score 62
      elevated · 0–100
      Fundamentals
      Excellent
      Revenue growth +15%
      Y/Y
      Gross margin 199%
      contracting
      EPS growth +75%
      Y/Y
      Free cash flow $48.3M
      Valuation P/E 226.1
      rich
      Balance sheet $98.9M
      net cash
      Quant / Vol
      risk profile
      High
      Volatility 47%
      annualized · 1-yr
      Max drawdown −39%
      past year
      ATR 3.6%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Beat or met 3 of last 3
      Latest guidance · from the 8-K filed Jul 23, 2026
      Worldwide revenue · Full year 2026 Initiated $602M – $610M
      prior FY $534.53M midpoint +13.4% Y/Y
      Adjusted EBITDA · Full year 2026 Raised $85M – $89M
      Jan 12, 2026 $80M – $82M changed to Jul 23, 2026 $85M – $89M
      Net income per share · Full year 2026 Initiated $0.05 – $0.13
      prior FY $-0.24 midpoint +137.5% Y/Y
      Adjusted earnings per share · Full year 2026 Initiated $0.24 – $0.32
      Prior guidance period ended · from the 8-K filed Oct 29, 2025
      Revenue · Full year 2025 $532M – $534M
      Adjusted EBITDA · Full year 2025 $55M – $57M
      Guided vs delivered · last 3 settled
      Revenue Full year 2025
      guided $532M – $534M
      $534.53M Beat +0.3%
      Revenue full year 2024
      guided $459M – $466M
      $465.31M In line
      Full-year 2023 revenues full-year 2023
      guided $394M – $396M
      $399.25M Beat +1.1%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Buy
      1 · 2 · 4
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +46% Bullish
      Price vs 50-day avg
      +37% Bullish
      RSI (14)
      84 Bearish
      MACD trend
      Positive Bullish
      52-week position
      100% Bullish
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bullish · 3 of 6
      Trend (MA cross) No cross
      50d $36 › 200d $34 — 50d above 200d
      Institutional flow Accumulating
      +13% holders QoQ · +55 funds added
      Insider flow Distributing
      Net -$1.7M over 90 days · 100% sells
      Short interest Falling
      7.60% of float · ▼ -20.6% MoM · 3.7 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      252 holders — near 3-yr high, broad support
      Price context
      position in its 52-week range
      Range low $26 Now $49 · 100% Range high $49
      vs 200-day avg +46% vs 50-day avg +37%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Adjusted earnings per share non-GAAP $0.18 second quarter 2026 —
      Cash generation $21.6M second quarter 2026 —
      Non-GAAP adjusted income (adjusted EBITDA) non-GAAP 27.29M Three Months Ended June 30, 2026 —
      GAAP → non-GAAP reconciliation
      GAAP Net income (loss), as reported $8.96M
      +$471K Income tax expense
      +$239K Other expense (income), net
      +$5.31M Depreciation and amortization expense
      +$12.31M Share-based compensation expense
      +$0K Acquired in-process research & development expense
      = Non-GAAP adjusted income (adjusted EBITDA) $27.29M
      Adjusted income (loss) per share non-GAAP $0.06 Q4 2025 —
      Adjusted loss per share non-GAAP -$0.11 Full Year 2025 —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Medical Instruments & Supplies — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      ATRC
      AtriCure, Inc.
      this stock
      		$2.42B +23.8% +15.4% 226.1 7.6%
      ISRG
      Intuitive Surgical Inc
      		 $134.48B -33.1% +20.5% 43.7 1.9%
      BDX
      Becton Dickinson & Co
      		 $51.11B — +8.2% — 3.7%
      MDLN
      Medline Inc.
      		 $44.96B -18.4% +11.5% — 2.6%
      ALC
      Alcon Inc
      		 $35.25B -6.6% +10.5% — 2.8%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      252
      % held
      103.5%
      Net QoQ
      +2.6M sh
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      262
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      3.9M
      Days to cover
      3.7d
      Change
      -1.0M sh
      View
      Short Volume
      Short vol %
      65%
      As of
      Aug 21, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      53
      Value
      $1.8K
      As of
      Jul 22, 2026
      View
      Off-Exchange
      Off-exchange %
      44.6%
      Week of
      Jul 13, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net selling
      Net (90d)
      -$1.7M
      Buyers / Sellers
      0 / 5
      Buyers Sellers
      View
      Congressional Trades Buy
      Member
      Gilbert Cisneros
      Amount
      $1.0K–$15.0K
      Traded
      Mar 3, 2026
      View
      Financials
      Financials
      Revenue (FY)
      $534.5M
      Net income (FY)
      $-11.4M
      EPS diluted
      $-0.24
      View
      Filings
      SEC Filings
      Latest
      Investor Event Transcript
      Filed
      Aug 11, 2026
      This year
      12
      View
      Proposed Sales
      Value
      $139.0K
      Shares
      3.6K
      Filed
      Aug 5, 2026
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 11, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      ATRC +10.6% +39.8% +58.4% +29.7% +23.8%
      SPY -1.4% +3.6% +11.6% +2.5% +12.3%
      vs SPY +11.9% +36.2% +46.8% +27.2% +11.5%
      Key facts CIK 1323885 CUSIP 04963C209 13F (30d) 235 filings 230 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)